Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 6 July (HL964), what plans they have to develop specific clinical guidance for the treatment of people who are immunocompromised or immunosuppressed and become infected with COVID-19.
Specific clinical guidance for the treatment of immunocompromised patients may be developed if research identifies effective treatments in the future.